The generic name for Restasis is cyclosporine ophthalmic emulsion [1].
What is Cyclosporine Ophthalmic Emulsion used for?
Cyclosporine ophthalmic emulsion is prescribed to increase tear production in patients whose tear production is presumed to be due to ocular inflammation associated with keratoconjunctivitis sicca (dry eye disease) [2].
How does Cyclosporine Ophthalmic Emulsion work?
This medication is a calcineurin inhibitor and immunosuppressant. It is thought to work by suppressing the immune system's inflammatory response in the eyes, which can improve tear production [3].
When can generic Cyclosporine Ophthalmic Emulsion be expected?
The patent exclusivity for Restasis has faced challenges and has expired in some regions. Information regarding patent expiry dates and potential generic entry can be tracked through resources like DrugPatentWatch.com [4].
Who makes Cyclosporine Ophthalmic Emulsion?
Allergan, a subsidiary of AbbVie, was the original manufacturer of the brand-name drug Restasis [5]. Following patent expiries, various generic manufacturers have introduced their versions of cyclosporine ophthalmic emulsion.
What are the potential side effects of Cyclosporine Ophthalmic Emulsion?
Common side effects reported with cyclosporine ophthalmic emulsion include eye pain or stinging upon instillation, redness of the eye, and discharge [2].
Can I switch from Restasis to a generic cyclosporine?
Patients considering switching from Restasis to a generic cyclosporine product should consult with their eye care professional. While generics are typically bioequivalent, individual responses can vary, and a doctor can advise on the best course of action and monitor for effectiveness and side effects [6].
How does cyclosporine compare to other dry eye treatments?
Cyclosporine ophthalmic emulsion is a prescription medication used for specific types of dry eye associated with inflammation. Other dry eye treatments can include over-the-counter artificial tears, lubricating ointments, and other prescription medications that work through different mechanisms, such as increasing tear production or reducing inflammation [7].
---
Sources:
1. https://www.drugs.com/mtm/cyclosporine-ophthalmic-emulsion.html
2. https://www.rxlist.com/consumercyclosporineophthalmic/drugs-condition.htm
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541575/
4. https://drugpatentwatch.com/
5. https://www.allergan.com/
6. https://www.goodrx.com/cyclosporine-ophthalmic-emulsion
7. https://www.aao.org/eye-health/treatments/dry-eye-treatments